Contributed By Pakharenko & Partners (Kyiv)
Advertising for medicines does not require any prior authorisation or notification.
There is an option of applying to the AMCU for obtaining a conclusion in the form of recommendatory explanations on compliance of advertising activities with legislation (regarding dissemination of information that may mislead the public). This reduces the risk of non-compliance with the law; however, the term for providing explanations is rather long. It is important to note that the fact that such a conclusion was obtained by a certain company has no constitutive effect as it is not of obligatory nature.